Research Article| Volume 50, ISSUE 3, P221-224, July 1956

Chlorpromazine in asthma, chronic bronchitis and emphysema

      This paper is only available as a PDF. To read, Please Download here.


      Chlorpromazine was given over prolonged periods to fifty-four patients with bronchospasm due to asthma, chronic bronchitis or emphysema. Symptomatic improvement occurred in 59 per cent. of all cases; it was most frequent in the group in which emotional factors were predominant. Side effects were few and unobtrusive.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Respiratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Broglie M.
        • Jörgensen G.
        • Voss G.
        Ärztl. Wscht. 1953; 8: 1148
        • Robinson K.C.
        • Zuck D.
        Lancet. 1954; 1: 1349